Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
KLRS holding history
Kalaris Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KLRS overviewAll 13F holders of KLRSFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −3,030−100.0% | Sold out | Holders |
| Q3 2023 | 3,030 | $6.51K | <0.1% | +3,030 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −348−100.0% | Sold out | Holders |
| Q1 2023 | 348 | $1.37K | <0.1% | −342−49.6% | Reduced | Holders |
| Q4 2022 | 690 | $3.54K | <0.1% | +342+98.3% | Added | Holders |
| Q3 2022 | 348 | $3.00K | <0.1% | +348 | New | Holders |